S. Accardi

A phase 1b trial of selinexor, a first-in-class selective inhibitor of nuclear export (SINE), in combination with doxorubicin in patients with advanced soft tissue sarcomas (STS).

J. Lewin, E. Malone, Abha A. Gupta, 2021, European journal of cancer.

Investigations of the supramolecular host properties of a fluorescent bistren cage compound

P. Boland, B. Wagner, Carrie A. SnowC.A. Snow, 2009 .

EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression

Trevor J Pugh, A. Oza, T. Pugh, 2020, Clinical Cancer Research.